NeuraMetrix
The primary challenge with neurodegenerative diseases and psychiatric disorders is that existing biomarkers are neither objective, detailed, nor cannot be easily reproduced. NeuraMetrix’s goal is to enable dramatically better care of patients with these diseases and disorders by providing physicians and researchers with an exceptionally precise and accurate biomarker measurement of brain health. For more information see https://www.neurametrix.com/neurametrix-tc/our-solution
Key Benefits
- Neurologists and Psychiatrists will be able to: Diagnose patients before the disease has permanently damaged the brain, track patients longitudinally with a more objective measure to assess disease, progression or regression and assess the effectiveness of changes in disease and rehabilitation management
- Biotech and Pharmaceutical companies will be able to: Remove any patients from the cohort where the disease has already progressed ahead of where the drugs can have an impact, get greater insight in to how their therapeutic responds and measure cognitive side effects of their therapeutics